US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Difficile Infections (Clostridium Difficile Associated Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Clostridium Difficile Infections (Clostridium Difficile Associated Disease), complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014
11/17/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Global Fabry Disease Market 2015-2019
11/5/2014 | published by: TechNavio - Infiniti Research Ltd.
... can result in symptoms such as fatigue, angiokeratoma, tinnitus, kidney failure, heart disorders, and nervous system problems. Fabry disease results from mutations in the galactosidase (GLA) gene, resulting in decreased activity or complete absence of ...  |  read more...
USD 2,500
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019
11/3/2014 | published by: MarketsandMarkets
... such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, ...  |  read more...
USD 4,650
Anthrax Global Clinical Trials Review, H2, 2014
11/17/2014 | published by: GlobalData
... relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Bone Degeneration - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Bone Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Memory Impairment - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Memory Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cataract - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Cataract, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Arterial Thrombosis - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Arterial Thrombosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Cerebral Infarction (Brain Infarction), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Ocular Pain - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Ocular Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Skin And Soft Tissue Infections - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Skin And Soft Tissue Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Exocrine Pancreatic Insufficiency - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Exocrine Pancreatic Insufficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Swine Influenza - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Swine Influenza, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Proliferative Vitreoretinopathy (PVR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Vasomotor Symptoms of Menopause - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Vasomotor Symptoms of Menopause, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Abdominal Aortic Aneurysms - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Abdominal Aortic Aneurysms, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Endothelial Dysfunction - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Endothelial Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ischemic Cerebral Stroke - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Ischemic Cerebral Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Pseudomonas Aeruginosa Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Prostate Cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Prostate Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
HIV Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Non-Hodgkin Lymphoma Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Non-Hodgkin Lymphoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Multiple Sclerosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Multiple Sclerosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
1    3    5  6  7  8  9  10